טוען...
Clinical trial design and new therapies for pulmonary arterial hypertension
Until 20 years ago the treatment of pulmonary arterial hypertension (PAH) was based on case reports and small series, and was largely ineffectual. As a deeper understanding of the pathogenesis and pathophysiology of PAH evolved over the subsequent two decades, coupled with epidemiological studies de...
שמור ב:
| הוצא לאור ב: | Eur Respir J |
|---|---|
| Main Authors: | , , , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
European Respiratory Society
2019
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6351342/ https://ncbi.nlm.nih.gov/pubmed/30545975 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/13993003.01908-2018 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|